US Bancorp’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
Other funds holding ALT
DTC
TCM
RCM
US Bancorp's ALT Position: Q2 2026 in Review
US Bancorp sold out of Altimmune (ALT) in Q2 2026, closing a stake of 890 shares — an estimated $2.74K sold.
US Bancorp first reported a position in ALT in Q2 2013 and held it in 18 quarters. The position peaked at $202K in Q1 2024. 210 funds tracked by Wall St. Rank hold ALT as of Q2 2026.
- US Bancorp reported no remaining Altimmune position as of Q2 2026 after selling out during the quarter.
- US Bancorp sold 890 Altimmune shares in Q2 2026, an estimated $2.74K.
- US Bancorp first reported a position in Altimmune in Q2 2013 and held it in 18 quarters.
- US Bancorp's Altimmune position peaked at $202K in Q1 2024.
- 210 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.
Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.